A Study of MabThera (Rituximab) Addition to Regularly Prescribed Chemotherapy in Patients With Untreated Mantle Cell Lymphoma.

NCT01144403 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

8

Enrollment

INDUSTRY

Sponsor class

Conditions

Diffuse Large B-Cell Lymphoma

Interventions

DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: Mitoxantrone
DRUG: Rituximab

Sponsor

Hoffmann-La Roche